CD19 and heart lymphoma: Here, we present the first documented case of PCL achieving sustained complete response (CR) through a novel therapeutic approach combining autologous hematopoietic stem cell transplantation (ASCT) with sequential tandem CD19/20 chimeric antigen receptor T-cell (CAR-T) therapy.